Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / United Kingdom

Innovation Action · Running

GreenNanoBone Sustainable 4D hydrogels functionalised with plant-based nanoparticles for bone regeneration in cancer patients

Coordinator
The University of Liverpool, United Kingdom
Runs
1 June 2025 to 31 May 2029
Status
Running
EU funding
€8.6m
Total cost
—
Partners
18 organisations in 12 countries
Type
Innovation Action
Grant agreement
101177877

What the project is doing

In the project's own words, from its summary on CORDIS.

PROBLEM: Medical-related-osteonecrosis of jaw (MRONJ) is a rare, but severe side effect of bone-targeting agents (BTAs), such as bisphosphonates. These agents are prescribed to survivors of breast cancer where they reduce the risk of secondary bone cancer. Unfortunately some people develop MRONJ, where progressive destruction of the jawbone leads to frequent infections, inability to eat and risk of malnutrition. MRONJ treatment focuses on controlling infection, pain and bone death through long courses of antimicrobial agents, contributing to development of antimicrobial resistance.

Currently, ~12,000 people across Europe and the UK suffer from MRONJ. As people survive cancer longer, the number of cases is increasing. We urgently need a new prevention and treatment strategy for MRONJ.INNOVATION: GreenNanoBone will develop and validate sustainable, biocompatible, bioactive and antimicrobial 4D material to promote bone and tissue regeneration in a new strategy to prevent and treat MRONJ. The material will be injectable or printable as a scaffold for use in non-invasive surgical procedures.

We will use AI to refine the properties of our plant-derived materials, test them using pre-clinical models, and ensure that they can be manufactured to medical standards. IMPACT: We address a clinical need and will reveal the pathophysiological mechanism of MRONJ in readiness for Phase I clinical trials (TLR-6) by the end of the project. In the longer term GreenNanoBone will dramatically increase quality of life for MRONJ patients and open up exciting possibilities for treating complex fractures and other skeletal conditions.

We will develop a sustainable manufacturing process using recycling and clean raw material from a food (potato) waste side stream. The technology will enable production scale-up using climate-neutral methods. Our work will support European industries to undergo a Green Transformation and develop new markets, products, and services, boosting competitiveness.

Topics

Who is involved

OrganisationCityCountryRole
The University of LiverpoolLiverpoolUnited KingdomCoordinator
Eurice European Research and Project Office GmbHSt IngbertGermanyParticipant
Mybiotech GmbHUberherrnGermanyParticipant
Aarhus UniversitetAarhus CDenmarkParticipant
Aarhus UniversitetshospitalAarhusDenmarkParticipant
Kobenhavns UniversitetKobenhavnDenmarkParticipant
Asphalion SLBarcelonaSpainParticipant
Helsingin YliopistoHelsinkiFinlandParticipant
Tampereen Korkeakoulusaatio SrTampereFinlandParticipant
F6s EU Tech Innovation Network DacDublinIrelandParticipant
Luxembourg Institute of Science and TechnologyEsch Sur AlzetteLuxembourgParticipant
Asociatia de Cercetare a Maladiilor CroniceOrheiMoldovaParticipant
Stichting Amsterdam UmcAmsterdamNetherlandsParticipant
Universitetet I BergenBergenNorwayParticipant
Gdanski Uniwersytet MedycznyGdanskPolandParticipant
Uniwersytet JagiellonskiKrakowPolandParticipant
Universidade De AveiroAveiroPortugalParticipant
Guys and St Thomas' Nhs FoundationtrustLondonUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI